Patient-Reported Outcomes Patient-Reported Outcomes
Chapman & Hall/CRC Biostatistics Series

Patient-Reported Outcomes

Measurement, Implementation and Interpretation

    • $72.99
    • $72.99

Publisher Description

However, exciting new developments are on the verge of changing the treatment of this debilitating disorder. Two anabolic agents, the parathyroid hormone (PTH) and the fluoride ion, show tremendous promise as tools for building and retaining bone - with no adverse side effects. Anabolic Treatments for Osteoporosis is a comprehensive account of the latest studies that have been carried out on these two agents, and a thorough assessment of their prospects as osteoporosis therapeutics. This unique book combines basic science and up-to-date clinical data to present a complete picture of this breakthrough in the treatment of a globally significant health issue.

GENRE
Science & Nature
RELEASED
2013
December 20
LANGUAGE
EN
English
LENGTH
351
Pages
PUBLISHER
CRC Press
SELLER
Taylor & Francis Group
SIZE
10.4
MB
Design and Analysis of Subgroups with Biopharmaceutical Applications Design and Analysis of Subgroups with Biopharmaceutical Applications
2020
Statistical Topics in Health Economics and Outcomes Research Statistical Topics in Health Economics and Outcomes Research
2017
Dose Finding and Beyond in Biopharmaceutical Development Dose Finding and Beyond in Biopharmaceutical Development
2024
A Practical Approach to Quantitative Validation of Patient-Reported Outcomes A Practical Approach to Quantitative Validation of Patient-Reported Outcomes
2022
Phase II Clinical Development of New Drugs Phase II Clinical Development of New Drugs
2017
Real-World Evidence in Drug Development and Evaluation Real-World Evidence in Drug Development and Evaluation
2021
Medical Risk Prediction Models Medical Risk Prediction Models
2021
Biomarker Analysis in Clinical Trials with R Biomarker Analysis in Clinical Trials with R
2020
Biosimilar Clinical Development: Scientific Considerations and New Methodologies Biosimilar Clinical Development: Scientific Considerations and New Methodologies
2016
Innovative Methods for Rare Disease Drug Development Innovative Methods for Rare Disease Drug Development
2020
Statistical Design, Monitoring, and Analysis of Clinical Trials Statistical Design, Monitoring, and Analysis of Clinical Trials
2021